awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28082858-18A5EF5D-07F9-4059-B2B9-82059FA24BDF
Q28082858-18A5EF5D-07F9-4059-B2B9-82059FA24BDF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082858-18A5EF5D-07F9-4059-B2B9-82059FA24BDF
Next generation of weight management medications: implications for diabetes and CVD risk
P2860
Q28082858-18A5EF5D-07F9-4059-B2B9-82059FA24BDF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082858-18A5EF5D-07F9-4059-B2B9-82059FA24BDF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
23c64cd98c398ad7fbbc7227a8fb289acd1d6771
P2860
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)